Cargando…
Taxifolin Suppresses Inflammatory Responses of High-Glucose-Stimulated Mouse Microglia by Attenuating the TXNIP–NLRP3 Axis
Type 2 diabetes mellitus is associated with an increased risk of dementia, potentially through multifactorial pathologies, including neuroinflammation. Therefore, there is a need to identify novel agents that can suppress neuroinflammation and prevent cognitive impairment in diabetes. In the present...
Autores principales: | Iwasa, Masayo, Kato, Hisashi, Iwashita, Kaori, Yamakage, Hajime, Kato, Sayaka, Saito, Satoshi, Ihara, Masafumi, Nishimura, Hideo, Kawamoto, Atsuhiko, Suganami, Takayoshi, Tanaka, Masashi, Satoh-Asahara, Noriko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302635/ https://www.ncbi.nlm.nih.gov/pubmed/37375642 http://dx.doi.org/10.3390/nu15122738 |
Ejemplares similares
-
Novel Therapeutic Potentials of Taxifolin for Obesity-Induced Hepatic Steatosis, Fibrogenesis, and Tumorigenesis
por: Inoue, Takayuki, et al.
Publicado: (2023) -
Taxifolin: A Potential Therapeutic Agent for Cerebral Amyloid Angiopathy
por: Saito, Satoshi, et al.
Publicado: (2021) -
Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives
por: Tanaka, Masashi, et al.
Publicado: (2019) -
N-Lobe of TXNIP Is Critical in the Allosteric Regulation of NLRP3 via TXNIP Binding
por: Cheng, Fengyu, et al.
Publicado: (2022) -
Taxifolin for Cognitive Preservation in Patients with Mild Cognitive Impairment or Mild Dementia
por: Hattori, Yorito, et al.
Publicado: (2023)